C. Dayen

发表

Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non-small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study.

O. Molinier, J. Mazières, G. Zalcman, 2020, European journal of cancer.

Orai3-Mediates Cisplatin-Resistance in Non-Small Cell Lung Cancer Cells by Enriching Cancer Stem Cell Population through PI3K/AKT Pathway

L. Garçon, H. Sevestre, H. Ouadid‐Ahidouch, 2021, Cancers.

Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies.

B. Asselain, O. Molinier, F. Goupil, 2013, Lung cancer.

Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small–cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB)

C. Marquette, J. Vergnon, L. Thiberville, 2019, PloS one.

New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases.

O. Molinier, D. Debieuvre, F. Paganin, 2017, Journal of thoracic disease.

[Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010].

B. Asselain, M. Zureik, O. Molinier, 2010, Revue de pneumologie clinique.

FRESC: French Real world Extensive stage SCLC Cohorts: A retrospective study on patient characteristics and treatment strategy based on KBP-2010.

D. Pau, D. Debieuvre, L. Falchero, 2021, Lung cancer.

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.

P. Lamy, J. Pujol, G. Zalcman, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study.

N. Normanno, O. Molinier, M. Denis, 2019, Journal of thoracic disease.

Symptom and Quality of Life Improvement in LUX‐Lung 8, an Open‐Label Phase III Study of Second‐Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First‐Line Platinum‐Based Chemotherapy

E. Felip, J. Soria, S. Gadgeel, 2018, Clinical lung cancer.

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

Nancy E. Marion, B. Delclaux, B. Asselain, 2022, The Lancet regional health. Europe.

Bacterial infection profiles in lung cancer patients with febrile neutropenia

P. Dumont, F. Lescure, J. Schmit, 2011, BMC infectious diseases.

Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies.

B. Delclaux, B. Asselain, O. Molinier, 2019, Bulletin du cancer.

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors

F. Ducray, J. Honnorat, V. Desestret, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Paecilomyces variotii fungemia in a patient with multiple myeloma: case report and literature review.

F. Lescure, A. Smail, J. Schmit, 2005, The Journal of infection.

[Spontaneous rupture of the esophagus or Boerhaave syndrome. Report of 3 cases and review of the literature].

T. Reix, M. Auquier, V. Jounieaux, 2001, Revue des maladies respiratoires.

[Lemierre syndrome: unusual, but still possible].

V. Strunski, V. Jounieaux, M. Monge, 2003, Annales de medecine interne.

Primary meningococcal arthritis in a COVID-19 18-year-old man: a case report and review of the literature

E. Lecuyer, Y. Douadi, B. Brihaye, 2021, BMC Infectious Diseases.

Échoendoscopie endobronchique (EBUS) : le point de la question

L. Thiberville, V. Jounieaux, P. Ramon, 2012 .

A case of Francisella tularensis meningitis in a 64-year-old man treated with quinolones.

E. Lecuyer, Y. Douadi, C. Dayen, 2021, Infectious diseases now.

Une complication inhabituelle d’une thoracostomie

C. Poulet, E. Lecuyer, Y. Douadi, 2008 .

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial.

J. Pujol, G. Zalcman, D. Moro-Sibilot, 2014 .

[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].

B. Milleron, G. Zalcman, D. Moro-Sibilot, 2018, Revue des maladies respiratoires.

[First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals].

B. Asselain, O. Molinier, F. Goupil, 2017, Revue des maladies respiratoires.

[Relationship between primary lung cancer and tobacco consumption. Results of the KBP-2010-CPHG study by the French College of General Hospital Respiratory Physicians].

V. Frappat, D. Debieuvre, M. Grivaux, 2016, Revue des maladies respiratoires.

Bronchial Fistula Associated with Sunitinib in a Patient Previously Treated with Radiation Therapy

M. Andréjak, D. Basille, E. Lecuyer, 2010, The Annals of pharmacotherapy.

Noninvasive Ventilation Using a Mouthpiece in Patients with Chronic Obstructive Pulmonary Disease and Acute Respiratory Failure

V. Jounieaux, C. Dayen, J. Glerant, 2007, Respiration.

Aortic endostent followed by extended pneumonectomy for T4 lung cancer.

M. Riquet, P. Bagan, P. Berna, 2011, The Annals of thoracic surgery.

[Effectiveness of erlotinib in Critical Care Unit in patients with non-small cell lung cancer with EGFR mutation].

M. Dewolf, W. Khamis, E. Lecuyer, 2017, Revue de pneumologie clinique.

Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study.

P. Tomasini, F. Guisier, R. Gervais, 2023, Lung cancer.